Search

You searched for "lesions"

2417 results found

Skills training and setting up of nurse practitioners led intravitreal treatment (IVT) workshop at the RCOphth Congress

17 April 2023 | Awards, Conferences & Anniversaries, Company Profiles
The Medical Retina team at Great Western NHS Hospital, Swindon will be running a first of its kind skills training workshop at RCOphth Annual Congress, Birmingham on 24 May ’23.

ANZGS Congress 2026

13 February 2026 -15 February 2026
"As Chair of the Australian and New Zealand Glaucoma Society I am pleased to invite you to the 2026 ANZGS Congress which will be held in Sydney from 13 – 15 February 2026. The 2025 ANZGS Congress was held in...

AOP welcomes focus on improved patient outcomes in Pharmacy Supervision Review Group report

21 August 2023 | AOP, pharmacy review, PSRG
Recommendations review legislative framework for the future delivery of pharmacy.

Comparison of corneal deformation parameters in keratoconic and normal eyes

1 February 2018 | | EYE - Cataract, EYE - Refractive
This study set out to compare biomechanical properties between normal and keratoconic eyes. It was a retrospective study evaluating 89 eyes (47 normal, 42 keratoconic) and a validation arm of 72 eyes (33 normal, 39 keratoconic) using a high speed...

Management of diabetic macular oedema (DMO)

1 February 2018 | | EYE - Vitreo-Retinal | Anti-VEGF therapy, Diabetic macular edema, Steroids
The authors present guidelines on current diagnostic and therapeutic procedures in the management of DMO. Fluorescein angiography (FA) and optical coherence tomography (OCT) are recommended before starting treatment to help diagnose and stage DMO, and can be repeated if there...

High dose (2.5mg) bevacizumab for postradiation cystoid macular oedema

1 April 2017 | | EYE - Pathology, EYE - Oncology | Anti-VEGF, Cystoid macular edema, Melanoma, Radiation damage, Radiotherapy, Tumor
The authors present a retrospective, interventional case series investigating the efficacy of high dose (2.5mg/0.1ml) intravitreal bevacizumab in the treatment of persistent postradiation (Iodine-125 plaque brachytherapy for uveal melanoma) cystoid macular oedema (CME). Persistent CME was defined as increased or...
Ophthalmologica journal cover image.

Intravitreal dexamethasone in diabetic macular oedema (DMO) - enhancing the response to anti-VEGF in non- or poor responders

3 February 2023 | | EYE - Vitreo-Retinal | Aflibercept, Anti-VEGF, Dexamethasone implant, Diabetic macular oedema, Persistent, Ranibizumab, Resistant
This study aimed to describe the outcomes of a switch back from DEXi (dexamethasone implant) to anti-VEGF therapy in eyes that were treated temporarily with DEXi after an initial poor response to anti VEGF. Twenty-three eyes of 17 patients were...

Recurrent unilateral preseptal cellulitis secondary to herpes simplex virus infection

3 April 2023 | | EYE - General
Introduction Periorbital (sometimes called preseptal cellulitis) is a common condition which on its own is not normally an ophthalmic or surgical emergency, however it has the potential to cause severe and serious morbidity in cases where the infection has crossed...

Therapy for limbal stem cell deficiency: cell fate after limbal stem cell transplants

1 October 2014 | | EYE - Cornea
“The beauty of scientific research lies in that the search for answers often yields yet more questions.” A large body of evidence points to the corneoscleral limbal location as the repository of putative epithelial stem cells [1]. Thoft proposed the...

The VISION 2020 LINKS Programme: Cascading leadership training in Calabar, Nigeria

1 October 2016 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
The VISION 2020 LINKS Programme has initiated ‘LEAD FORWARD’, an innovative leadership development project incorporating a commitment to cascade training and participate in achievable quality or service improvement projects. The project provides opportunities to apply leadership skills in practice as...

RCOphth Annual Congress - Day 1

23 May 2022 |
Follow all the updates from the first day of the RCOphth 2022 Annual Congress here.

The management of chronic uveitis

1 October 2015 | | EYE - Vitreo-Retinal
A 40-year-old company executive is referred from another unit with recurrent anterior and posterior uveitis for 12 months and the inflammatory markers are raised. Review of systems This is a case of chronic uveitis which needs a thorough workup and...